-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on MediWound, Lowers Price Target to $30

Benzinga·08/14/2026 17:10:12
语音播报
Oppenheimer analyst Jeff Jones maintains MediWound (NASDAQ:MDWD) with a Outperform and lowers the price target from $32 to $30.